Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

被引:145
|
作者
van Hoek, Albert Jan [1 ]
Sheppard, Carmen L. [2 ]
Andrews, Nick J. [1 ]
Waight, Pauline A. [1 ]
Slack, Mary P. E. [2 ]
Harrison, Timothy G. [2 ]
Ladhani, Shamez N. [1 ]
Miller, Elizabeth [1 ]
机构
[1] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England
[2] Publ Hlth England, Resp & Vaccine Preventable Bacteria Reference Uni, London NW9 5EQ, England
关键词
Nasopharynx; Carriage; Colonisation; Streptococcus pneumoniae; Pneumococcus; Conjugate vaccine; Vaccine impact; Post-PCV13; Herd immunity; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; SEROTYPE REPLACEMENT; 13-VALENT; IMMUNOGENICITY; DISEASE;
D O I
10.1016/j.vaccine.2014.03.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background/Aims: In April 2010 the 7-valent pneumococcal conjugate vaccine (PCV7) was replaced by the 13-valent PCV. We investigated pneumococcal carriage in children eligible for PCV7 or PCV13 and their household contacts. Methods: Eligible families in Hertfordshire and Gloucester were identified and a nasopharyngeal swab obtained from consenting household members between July 2012 and March 2013. Samples were cultured for Streptococcus pneumoniae and serotyped by standard methods. For each serotype the ratio of its prevalence in invasive pneumococcal disease (IPD) to its carriage prevalence (case:carrier ratio, CCR) was calculated. Results were compared with previous carriage studies in 2001/2002 and 2008/2009, before and after PCV7 introduction. Results: 217 households were included. Among <5-year olds 47.7% (95% confidence interval 41.8-53.5) were carrying a pneumococcus compared with 51.0% (95% CI: 44.0-58.0) in 2008/2009 and 48.4% (95% CI: 44.1-52.7) in 2001/2002. The odds of carrying a PCV7 serotype was significantly reduced in 2008/2009 (0.07,95% CI: 0.03-0.16) and 2012/2013 (0.01 95% CI: 0.00-0.07) relative to 2001/2002, while the odds of carrying any of the extra six PCV13 serotypes increased after PCV7 introduction (1.38, 95%CI: 0.73-2.59) but declined significantly after PCV13 introduction (0.05, 95%CI: 0.01-0.37). The CCRs for the frequently carried serotypes were relatively low, with the highest CCR observed for serotypes 7F, 19A, 3, 8, and 33F. Across the three carriage studies, CCR estimates were stable for nearly all serotypes. Conclusion: Carriage of additional PCV13 serotypes has rapidly reduced post-PCV13 introduction in both vaccinated and unvaccinated individuals with a continued decline in transmission of PCV7 serotypes. Carriage rates in children remain unchanged, but the low CCRs of replacing serotypes would be expected to further reduce overall IPD across all age groups. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4349 / 4355
页数:7
相关论文
共 50 条
  • [41] Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Chang, Bin
    Tamura, Kosuke
    Fujikura, Hiroyuki
    Watanabe, Hiroshi
    Tanabe, Yoshinari
    Kuronuma, Koji
    Fujita, Jiro
    Oshima, Kengo
    Maruyama, Takaya
    Abe, Shuichi
    Kasahara, Kei
    Nishi, Junichiro
    Kubota, Tetsuya
    Kinjo, Yuki
    Serizawa, Yusuke
    Shimbashi, Reiko
    Fukusumi, Munehisa
    Shimada, Tomoe
    Sunagawa, Tomimasa
    Suzuki, Motoi
    Oishi, Kazunori
    SCIENTIFIC REPORTS, 2022, 12 (01) : 3066
  • [42] Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine
    Sharma, Dolly
    Baughman, Wendy
    Holst, Amy
    Thomas, Stephanie
    Jackson, Delois
    Carvalho, Maria da Gloria
    Beall, Bernard
    Satola, Sarah
    Jerris, Robert
    Jain, Shabnam
    Farley, Monica M.
    Nuorti, J. Pekka
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : E45 - E53
  • [43] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
    Waight, Pauline A.
    Andrews, Nicholas J.
    Ladhani, Shamez N.
    Sheppard, Carmen L.
    Slack, Mary P. E.
    Miller, Elizabeth
    LANCET INFECTIOUS DISEASES, 2015, 15 (05): : 535 - 543
  • [44] Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
    Sigurdardottir, Sigurveig Th.
    Center, Kimberly J.
    Davidsdottir, Katrin
    Arason, Vilhjalmur A.
    Hjalmarsson, Bjorn
    Elisdottir, Ragnheidur
    Ingolfsdottir, Gunnhildur
    Northington, Robert
    Scott, Daniel A.
    Jonsdottir, Ingileif
    VACCINE, 2014, 32 (03) : 417 - 424
  • [45] Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Peterson, James T.
    Stacey, Helen L.
    MacNair, John E.
    Li, Jianing
    Hartzel, Jonathan S.
    Sterling, Tina M.
    Benner, Patrice
    Tamms, Gretchen M.
    Musey, Luwy K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 540 - 548
  • [46] Impact of 1.3-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
    Ruiz-Contreras, Jesus
    Picazo, Juan
    Casado-Flores, Juan
    Baquero-Artigao, Fernando
    Hernandez-Sampelayo, Teresa
    Otheo, Enrique
    Mendez, Cristina
    del Amo, Maria
    Balseiro, Cesar
    VACCINE, 2017, 35 (35) : 4646 - 4651
  • [47] Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England
    Moore, Catrin E.
    Paul, John
    Foster, Dona
    Mahar, Saeed A.
    Griffiths, David
    Knox, Kyle
    Peto, Timothy E.
    Walker, A. Sarah
    Crook, Derrick W.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (07): : 1001 - 1011
  • [48] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +
  • [49] Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
    Libwea, John Njuma
    Grondahl-Yli-Hannuksela, Kirsi
    Kobela, Marie
    Toropainen, Maija
    Nyholm, Outi
    Ndombo, Paul Koki
    Koulla-Shiro, Sinata
    Nohynek, Hanna
    Nuorti, J. Pekka
    Vuopio, Jaana
    Palmu, Arto A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 98 : 113 - 120
  • [50] Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine
    Susanna Esposito
    Leonardo Terranova
    Maria Francesca Patria
    Gian Luigi Marseglia
    Michele Miraglia del Giudice
    Alessandro Bodini
    Alberto Martelli
    Eugenio Baraldi
    Oscar Mazzina
    Claudia Tagliabue
    Amelia Licari
    Valentina Ierardi
    Mara Lelii
    Nicola Principi
    BMC Infectious Diseases, 16